AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
The hires come in the wake of completing a $43 million series B round of funding this summer.
Featured on Medical Marketing and Media by MM+M Staff
Cleerly, a company attempting to create a higher standard of care for heart disease, has tapped Brandon Atkinson as COO and Nick Nieslanik as CTO. The hires come weeks after Cleerly closed a $43 million series B round of funding this summer. Atkinson previously served as CEO of 46 Summits Consulting, while Nieslanik was formerly VP of engineering at Teladoc Health.
Read the full article HERE.
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...
Nasdaq interviews CEO Dr. James K. Min, one of their 18 “Brilliant Minds in Healthcare,” about Cleerly’s founding, his vision for the company, and...